Literature DB >> 15458426

Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection.

Paramit Chowdhury1, Steven H Sacks, Neil S Sheerin.   

Abstract

Infection of the urinary tract remains one of the most common infections affecting mankind. Renal epithelial cells, being one of the first cells to come into contact with invading organisms, are in a key position to coordinate host defense. The epithelium not only provides a physical barrier to infection, but can also augment the immune response via the production of a number of inflammatory mediators and antimicrobial proteins. Recent work has demonstrated that cells of the innate immune system, including epithelial cells, express toll-like receptors (TLRs), with the capacity to recognize bacterial components. Although the exact mechanisms remain unclear, engagement of TLRs can lead to epithelial cell activation and the production of inflammatory mediators. These include complement proteins, other bactericidal peptides, and chemotactic cytokines. The resulting inflammatory infiltrate serves to aid bacterial clearance, but can also lead to renal damage. In this review, we describe how renal epithelial cells contribute to the innate immune response to ascending urinary tract infection. We specifically relate previous work to more recent developments in this field. An improved understanding of the mechanisms involved may highlight potential therapeutic avenues to aid bacterial clearance and prevent the renal scarring associated with infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458426     DOI: 10.1111/j.1523-1755.2004.00896.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  How does the urothelium affect bladder function in health and disease? ICI-RS 2011.

Authors:  L A Birder; M Ruggieri; M Takeda; G van Koeveringe; S Veltkamp; C Korstanje; B Parsons; C H Fry
Journal:  Neurourol Urodyn       Date:  2012-01-24       Impact factor: 2.696

Review 2.  [Treatment and prophylaxis of recurrent urinary tract infections].

Authors:  B Banas; B K Krämer
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

Review 3.  Triggers of inflammation after renal ischemia/reperfusion.

Authors:  Joshua M Thurman
Journal:  Clin Immunol       Date:  2006-10-24       Impact factor: 3.969

4.  Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells.

Authors:  Ashok Kumar; Jing Zhang; Fu-Shin X Yu
Journal:  Microbes Infect       Date:  2005-09-15       Impact factor: 2.700

5.  Does the presence of vesicoureteral reflux affect in vitro uropathogenic E. coli growth rate in urine?

Authors:  Alper Soylu; Meral Karaman; Demet Alaygut; Seçil Arslansoyu Çamlar; Mehmet Türkmen; Salih Kavukçu
Journal:  Int Urol Nephrol       Date:  2015-12-17       Impact factor: 2.370

Review 6.  The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections.

Authors:  Brian Becknell; Megan Schober; Lindsey Korbel; John David Spencer
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-25       Impact factor: 5.091

7.  TLR-4 polymorphisms and leukocyte TLR-4 expression in febrile UTI and renal scarring.

Authors:  Meral Torun Bayram; Alper Soylu; Halil Ateş; Sefa Kızıldağ; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2013-04-24       Impact factor: 3.714

8.  Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes.

Authors:  David W Good; Thampi George; Bruns A Watts
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-22

Review 9.  The innate immune response in ischemic acute kidney injury.

Authors:  Hye Ryoun Jang; Hamid Rabb
Journal:  Clin Immunol       Date:  2008-10-14       Impact factor: 3.969

Review 10.  Antimicrobial mechanisms of the urinary tract.

Authors:  Milan Chromek; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2007-09-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.